Dow Up 0.76% Nasdaq Up 0.69%

AxoGen, Inc. (AXGN)

-NasdaqCM
2.54 Down 0.01(0.39%) Oct 24, 3:59PM EDT
Prev Close:2.55
Open:2.49
Bid:2.12 x 500
Ask:7.00 x 800
1y Target Est:5.50
Beta:1.49
Next Earnings Date:N/A
Day's Range:2.48 - 2.55
52wk Range:2.11 - 5.20
Volume:9,900
Avg Vol (3m):38,797
Market Cap:44.36M
P/E (ttm):N/A
EPS (ttm):-0.94
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AXGN

Comparison

Symbol% ChgMkt Cap
AXGNDown 0.39%44.36M
IARTUp 0.47%1.62B
JNJUp 0.49%290.86B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.35
Ex-Dividend Date:27-Jan-10

Analysts

Annual EPS Est (Dec-14) :-0.85
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AxoGen, Inc. operates as a medical technology company. It focuses on advancing the science and commercialization of peripheral nerve repair solutions. It offers a range of surgical nerve repair solutions, including Avance Nerve Graft, a processed ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback